Cargando…

Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia

Oxysterols (OHC) are biologically active cholesterol metabolites circulating in plasma that may be formed enzymatically (e.g. 24S-OHC, 25-OHC and 27-OHC) or by autoxidative mechanisms (e.g. 7-ketocholesterol, 7β-OHC and 25-OHC). Oxysterols are more soluble than cholesterol and are reported to exert...

Descripción completa

Detalles Bibliográficos
Autores principales: Dias, Irundika H.K., Milic, Ivana, Lip, Gregory Y.H., Devitt, Andrew, Polidori, M. Cristina, Griffiths, Helen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952874/
https://www.ncbi.nlm.nih.gov/pubmed/29501047
http://dx.doi.org/10.1016/j.redox.2018.02.014
_version_ 1783323277175816192
author Dias, Irundika H.K.
Milic, Ivana
Lip, Gregory Y.H.
Devitt, Andrew
Polidori, M. Cristina
Griffiths, Helen R.
author_facet Dias, Irundika H.K.
Milic, Ivana
Lip, Gregory Y.H.
Devitt, Andrew
Polidori, M. Cristina
Griffiths, Helen R.
author_sort Dias, Irundika H.K.
collection PubMed
description Oxysterols (OHC) are biologically active cholesterol metabolites circulating in plasma that may be formed enzymatically (e.g. 24S-OHC, 25-OHC and 27-OHC) or by autoxidative mechanisms (e.g. 7-ketocholesterol, 7β-OHC and 25-OHC). Oxysterols are more soluble than cholesterol and are reported to exert inflammatory, cytoprotective and apoptotic effects according to concentration and species. Esterified oxysterols have been analysed in people with dementia and cardiovascular diseases although there is no consistent relationship between oxysterol esters and disease. However, oxysterol esters are held in lipoprotein core and may not relate to the concentration and activity of plasma free oxysterols. Methodological limitations have challenged the analysis of free oxysterols to date. We have developed a fast, sensitive and specific quantitative LC-MS/MS, multiple reaction monitoring (MRM) method to target five oxysterols in human plasma with analyte recoveries between 72% and 82% and sensitivities between 5 and 135 pg/ml. A novel method was used to investigate the hypothesis that simvastatin may reduce the concentrations of specific plasma free oxysterols in hypercholesterolaemia. Twenty healthy male volunteers were recruited (aged 41–63 years); ten were asymptomatic with high plasma cholesterol > 6.5 mM and ten were healthy with normal plasma cholesterol (< 6.5 mM). Simvastatin (40 mg/day) was prescribed to those with hypercholesterolaemia. Plasma samples were taken from both groups at baseline and after three months. Simvastatin reduced plasma cholesterol by ~35% (p < 0.05) at the end of three months. Oxysterols generated by autoxidation (but not enzymatically) were elevated up to 45 fold in hypercholesterolaemic midlife men. Plasma oxysterols were restored to those of healthy controls after simvastatin intervention suggesting that autoxidation is either prevented by simvastatin directly or that autoxidation is less prevalent when plasma cholesterol concentrations are within the normal range.
format Online
Article
Text
id pubmed-5952874
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59528742018-05-16 Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia Dias, Irundika H.K. Milic, Ivana Lip, Gregory Y.H. Devitt, Andrew Polidori, M. Cristina Griffiths, Helen R. Redox Biol Research Paper Oxysterols (OHC) are biologically active cholesterol metabolites circulating in plasma that may be formed enzymatically (e.g. 24S-OHC, 25-OHC and 27-OHC) or by autoxidative mechanisms (e.g. 7-ketocholesterol, 7β-OHC and 25-OHC). Oxysterols are more soluble than cholesterol and are reported to exert inflammatory, cytoprotective and apoptotic effects according to concentration and species. Esterified oxysterols have been analysed in people with dementia and cardiovascular diseases although there is no consistent relationship between oxysterol esters and disease. However, oxysterol esters are held in lipoprotein core and may not relate to the concentration and activity of plasma free oxysterols. Methodological limitations have challenged the analysis of free oxysterols to date. We have developed a fast, sensitive and specific quantitative LC-MS/MS, multiple reaction monitoring (MRM) method to target five oxysterols in human plasma with analyte recoveries between 72% and 82% and sensitivities between 5 and 135 pg/ml. A novel method was used to investigate the hypothesis that simvastatin may reduce the concentrations of specific plasma free oxysterols in hypercholesterolaemia. Twenty healthy male volunteers were recruited (aged 41–63 years); ten were asymptomatic with high plasma cholesterol > 6.5 mM and ten were healthy with normal plasma cholesterol (< 6.5 mM). Simvastatin (40 mg/day) was prescribed to those with hypercholesterolaemia. Plasma samples were taken from both groups at baseline and after three months. Simvastatin reduced plasma cholesterol by ~35% (p < 0.05) at the end of three months. Oxysterols generated by autoxidation (but not enzymatically) were elevated up to 45 fold in hypercholesterolaemic midlife men. Plasma oxysterols were restored to those of healthy controls after simvastatin intervention suggesting that autoxidation is either prevented by simvastatin directly or that autoxidation is less prevalent when plasma cholesterol concentrations are within the normal range. Elsevier 2018-02-17 /pmc/articles/PMC5952874/ /pubmed/29501047 http://dx.doi.org/10.1016/j.redox.2018.02.014 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Dias, Irundika H.K.
Milic, Ivana
Lip, Gregory Y.H.
Devitt, Andrew
Polidori, M. Cristina
Griffiths, Helen R.
Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title_full Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title_fullStr Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title_full_unstemmed Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title_short Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
title_sort simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952874/
https://www.ncbi.nlm.nih.gov/pubmed/29501047
http://dx.doi.org/10.1016/j.redox.2018.02.014
work_keys_str_mv AT diasirundikahk simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia
AT milicivana simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia
AT lipgregoryyh simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia
AT devittandrew simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia
AT polidorimcristina simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia
AT griffithshelenr simvastatinreducescirculatingoxysterollevelsinmenwithhypercholesterolaemia